Familial encephalopathy with neuroserpin inclusion bodies
|
0.950 |
Biomarker
|
disease |
BEFREE |
Some of these regions are in close proximity to genes encoding essential proteins for neuronal functions and human neurodegenerative disorders such as epm2a (Lafora disease), serpini1 (familial encephalopathy with neuroserpin inclusion bodies) and il1rpl1 (mental retardation, X-linked 21).
|
30049290 |
2018 |
Familial encephalopathy with neuroserpin inclusion bodies
|
0.950 |
GeneticVariation
|
disease |
BEFREE |
Point mutations in the neuroserpin gene cause the autosomal dominant dementia familial encephalopathy with neuroserpin inclusion bodies or FENIB.
|
21115126 |
2011 |
Familial encephalopathy with neuroserpin inclusion bodies
|
0.950 |
GeneticVariation
|
disease |
BEFREE |
The dementia familial encephalopathy with neuroserpin inclusion bodies (FENIB) is caused by point mutations in the neuroserpin gene.
|
15291813 |
2004 |
Familial encephalopathy with neuroserpin inclusion bodies
|
0.950 |
Biomarker
|
disease |
MGD |
Impaired explorative behavior and neophobia in genetically modified mice lacking or overexpressing the extracellular serine protease inhibitor neuroserpin.
|
12837630 |
2003 |
Familial encephalopathy with neuroserpin inclusion bodies
|
0.950 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Association between conformational mutations in neuroserpin and onset and severity of dementia.
|
12103288 |
2002 |
Familial encephalopathy with neuroserpin inclusion bodies
|
0.950 |
GeneticVariation
|
disease |
BEFREE |
The serpinopathies include alpha(1)-antitrypsin (SERPINA1) deficiency and the newly characterized familial encephalopathy with neuroserpin inclusion bodies (FENIB) resulting from mutations in the neuroserpin (SERPINI1) gene.
|
12112652 |
2002 |
Familial encephalopathy with neuroserpin inclusion bodies
|
0.950 |
GermlineCausalMutation
|
disease |
ORPHANET |
Association between conformational mutations in neuroserpin and onset and severity of dementia.
|
12103288 |
2002 |
Familial encephalopathy with neuroserpin inclusion bodies
|
0.950 |
PosttranslationalModification
|
disease |
BEFREE |
Mutations of three different genes-amyloid precursor protein (APP), presenilin 1 (PS-1), presenilin 2 (PS-2)-have been found in early-onset autosomal dominant forms of AD, of the human microtubule associated-protein tau gene (MAPT) in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), of the BRI gene in familial British dementia, of the PI12 gene in familial encephalopathy with neuroserpin inclusion bodies.
|
11914409 |
2002 |
Familial encephalopathy with neuroserpin inclusion bodies
|
0.950 |
GeneticVariation
|
disease |
UNIPROT |
Mutant Neuroserpin (S49P) that causes familial encephalopathy with neuroserpin inclusion bodies is a poor proteinase inhibitor and readily forms polymers in vitro.
|
11880376 |
2002 |
Familial encephalopathy with neuroserpin inclusion bodies
|
0.950 |
GeneticVariation
|
disease |
UNIPROT |
Familial dementia caused by polymerization of mutant neuroserpin.
|
10517635 |
1999 |
Familial encephalopathy with neuroserpin inclusion bodies
|
0.950 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Familial encephalopathy with neuroserpin inclusion bodies
|
0.950 |
Biomarker
|
disease |
CTD_human |
|
|
|
Myoclonic Epilepsies, Progressive
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
We present two pediatric cases of progressive myoclonic epilepsy with SERPINI1 pathogenic variants that lead to a severe presentation; we highlight the importance of including this gene, previously known as causing an adult-onset dementia-epilepsy syndrome, in the genetic work-up of childhood-onset progressive myoclonic epilepsies.
|
28631894 |
2017 |
Myoclonic Epilepsies, Progressive
|
0.320 |
Biomarker
|
disease |
CTD_human |
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
|
25401298 |
2015 |
Myoclonic Epilepsies, Progressive
|
0.320 |
GeneticVariation
|
disease |
LHGDN |
In a French family with the S52R mutation of the neuroserpin gene, progressive myoclonic epilepsy was associated with a frontal syndrome.
|
17606885 |
2007 |
Schizophrenia
|
0.310 |
Biomarker
|
disease |
PSYGENET |
The relative abundances of HINT1, MDH1, and SERPINI1 mRNA in the DLPFC in individuals with schizophrenia and controls were measured by real-time quantitative polymerase chain reaction (Q-PCR) and for HINT1 expression by in situ hybridization.
|
15176481 |
2004 |
Schizophrenia
|
0.310 |
AlteredExpression
|
disease |
BEFREE |
The relative abundances of HINT1, MDH1, and SERPINI1 mRNA in the DLPFC in individuals with schizophrenia and controls were measured by real-time quantitative polymerase chain reaction (Q-PCR) and for HINT1 expression by in situ hybridization.
|
15176481 |
2004 |
Atypical Inclusion-Body Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
|
25401298 |
2015 |
Familial Progressive Myoclonic Epilepsy
|
0.300 |
Biomarker
|
disease |
CTD_human |
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
|
25401298 |
2015 |
Action Myoclonus-Renal Failure Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
|
25401298 |
2015 |
Biotin-Responsive Encephalopathy
|
0.300 |
Biomarker
|
disease |
CTD_human |
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
|
25401298 |
2015 |
Dentatorubral-Pallidoluysian Atrophy
|
0.300 |
Biomarker
|
disease |
CTD_human |
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
|
25401298 |
2015 |
May-White Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy.
|
25401298 |
2015 |
Dementia
|
0.140 |
Biomarker
|
disease |
BEFREE |
Forty-nine patients (19.9%) carried known pathogenic or novel, likely pathogenic, variants, involving both common (presenilin 1, presenilin 2, C9orf72, and granulin) and rare (optineurin, serpin family I member 1 and protein kinase cyclic adenosine monophosphate (cAMP)-dependent type I regulatory subunit beta) dementia-associated genes.
|
29525180 |
2018 |
Dementia
|
0.140 |
GeneticVariation
|
disease |
BEFREE |
There is a remarkable genotype-phenotype correlation between the degree of molecular destabilisation of the several variants of the neuroserpin protein, their propensity to self-associate and the age of onset of the dementia-epilepsy complex.
|
27618835 |
2016 |